(Reuters) -The U.S. Food and Drug Administration (FDA) issued a warning on Friday, advising consumers against inhaling ...

A recalled spinach artichoke dip is a Class II risk, and updates have been issued for the recall of chocolate nut and wafer ...

Robert F. Kennedy Jr., Secretary of Health and Human Services, which oversees the FDA, has promoted the falsehood that ...

A West Palm Beach home transformed into a drug den was raided by a SWAT team, revealing a substantial amount of drugs and ...

New research from the University of Otago, Christchurch—Ōtakau Whakaihu Waka, Ōtautahi, has exposed the large number of ...

Use of cystatin C for chronic kidney disease evaluation and sodium–glucose cotransporter-2 inhibitors as first-line therapy ...

The Food and Drug Administration has increased the risk level of two coffee creamers recalled in late February.

Research shows how specific natural nootropics can enhance memory, focus, and cognitive processing while potentially offering better safety profiles.

The Maryland-based biopharma joins Eli Lilly and Novo Nordisk in trialing a GLP-1 agonist for alcohol- and liver-related ...

Bronx based nonprofits joined dozens of other community based organizations and justice advocacy groups in sounding the alarm ...

As the potential of GLP-1 agonists for addiction gains traction, big pharma is also starting to take notice, namely the two ...

President Donald Trump is planning to invoke wartime authority in the coming days to rapidly accelerate the deportation of ...